Vaxcyte Inc (NASDAQ:PCVX)
| 51.37 Delayed Data As of 3:59pm ET |  -0.20 / -0.39%Today’s Change | 20.49 Today|||52-Week Range 54.97 | +7.13% Year-to-Date |
Latest PCVX News | Press Releases
No recent news for Vaxcyte Inc.
Today’s Trading
| Previous close | 51.57 |
| Today’s open | 51.70 |
| Day’s range | 50.63 - 53.48 |
| Volume | 25,660 |
| Average volume (3 months) | 570,110 |
| Market cap | $4.9B |
Data as of 3:59pm ET, 09/27/2023
Growth & Valuation
| Earnings growth (last year) | -78.72% |
| Earnings growth (this year) | +11.30% |
| Earnings growth (next 5 years) | -31.98% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.37 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | November 7, 2023 |
| EPS forecast (this quarter) | -$0.76 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$223.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
